Factors linked to diabetic foot ulcer severity and outcomes
Examining the Demographic, Clinical, and Laboratory Data of Patients With Diabetic Foot Ulcers Admitted to 5 Azar Hospital in 2024 (Registry Project)
This project looks at records of about 200 people with diabetic foot ulcers treated at 5 Azar Hospital in 2024 to see if blood tests and other health factors link to worse ulcers.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Sex | All |
| Sponsor | Golestan University of Medical sciences Academic / other |
| Locations | 1 site (Gorgan, Outside of the US) |
| Trial ID | NCT07188337 on ClinicalTrials.gov |
What this trial studies
This cross-sectional, retrospective analysis will review medical records of approximately 200 patients admitted with diabetic foot ulcers to 5 Azar Hospital, Gorgan, in 2024. Researchers will extract demographic information, clinical features, and laboratory values (hemoglobin, WBC, HbA1c, ESR, CRP) and grade ulcer severity using Wagner's classification. Statistical comparisons (independent t-test, chi-square, Fisher's exact test) and multivariable logistic regression will be used to identify factors associated with greater ulcer severity and adverse outcomes. Findings aim to highlight predictors that could inform prevention and management strategies for diabetic foot ulcers.
Who should consider this trial
Good fit: Adults admitted to 5 Azar Hospital in 2024 with a confirmed diabetic foot ulcer and complete demographic, clinical, and laboratory records are ideal candidates.
Not a fit: Patients with incomplete or missing records, non-diabetic foot ulcers, or whose care occurs outside this hospital are unlikely to benefit directly from the findings.
Why it matters
Potential benefit: If the study identifies reliable predictors, clinicians could target high-risk patients earlier to reduce infections, hospital stays, and amputations.
How similar studies have performed: Prior observational studies have reported associations between markers like HbA1c, WBC, and inflammatory markers with ulcer severity, so this project builds on existing evidence rather than testing a new treatment.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients admitted to 5 Azar Hospital, Gorgan, in 2024 * Diagnosis of diabetic foot ulcer (DFU) confirmed by medical records * Complete demographic, clinical, and laboratory data available in medical files Exclusion Criteria: * Incomplete or missing medical records * Patients with foot ulcers of non-diabetic etiology * Patients whose key laboratory data are unavailable
Where this trial is running
Gorgan, Outside of the US
- 5Th Azar Medical Center — Gorgan, Outside of the US, Iran (Recruiting)
Study contacts
- Study coordinator: Pezhman Kharazm
- Email: pezhmankh@goums.ac.ir
- Phone: 09111751861
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.